Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.452 EUR | +2.13% | -7.31% | -26.95% |
04-11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
03-26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
Evolution of the average Target Price on Valneva
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Valneva
HC Wainwright | |
Goldman Sachs | |
Kepler Cheuvreux | |
Guggenheim | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- VLA Stock
- Consensus Valneva